Page last updated: 2024-09-04

malvidin and Non-alcoholic Fatty Liver Disease

malvidin has been researched along with Non-alcoholic Fatty Liver Disease in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Gu, X; Li, X; Zhang, C; Zhu, H; Zou, W1

Other Studies

1 other study(ies) available for malvidin and Non-alcoholic Fatty Liver Disease

ArticleYear
Metformin in Combination with Malvidin Prevents Progression of Non-Alcoholic Fatty Liver Disease via Improving Lipid and Glucose Metabolisms, and Inhibiting Inflammation in Type 2 Diabetes Rats.
    Drug design, development and therapy, 2021, Volume: 15

    Topics: Animals; Anthocyanins; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Disease Progression; Drug Therapy, Combination; Glucose; Hypoglycemic Agents; Inflammation; Insulin Resistance; Lipid Metabolism; Male; Metformin; Non-alcoholic Fatty Liver Disease; Rats; Rats, Sprague-Dawley

2021